Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kaplan

Showing results (791-800 of 893) with videos related to

Pageof 90
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2019
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patientsSaul Eugene Rivkin, James Moon, Desiree S Iriarte, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 11, 2010
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit allGil Y Melmed, Brennan M Spiegel, Brian Bressler, et al.
The Journal of Urology|December 22, 2009
In vitro, ex vivo and in vivo isotherms for renal cryotherapyJennifer L Young, Surendra B Kolla, Donald L Pick, et al.
Inflammatory Bowel Diseases|October 23, 2018
Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness MethodologyAdam V Weizman, Geoffrey C Nguyen, Cynthia H Seow, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2022
Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN StudyOhad Atia, Eric I Benchimol, Natan Ledderman, et al.
World Journal of Gastroenterology|September 26, 2022
Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogueAlnoor Ramji, Karen Doucette, Curtis Cooper, et al.
Inflammatory Bowel Diseases|April 9, 2016
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness PanelShane M Devlin, Gil Y Melmed, Peter M Irving, et al.
Ebiomedicine|July 3, 2017
The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only StudyM Ellen Kuenzig, Jeff Yim, Stephanie Coward, et al.
Therapeutic Advances in Gastroenterology|June 20, 2022
The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018Yi-Ming He, Ren Mao, Gang Yuan, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBDCharles N Bernstein, Harminder Singh, Sanjay K Murthy, et al.
Pageof 90

Showing results (791-800 of 893) with videos related to

Sort By:
Pageof 90
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2019
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patientsSaul Eugene Rivkin, James Moon, Desiree S Iriarte, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 11, 2010
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit allGil Y Melmed, Brennan M Spiegel, Brian Bressler, et al.
The Journal of Urology|December 22, 2009
In vitro, ex vivo and in vivo isotherms for renal cryotherapyJennifer L Young, Surendra B Kolla, Donald L Pick, et al.
Inflammatory Bowel Diseases|October 23, 2018
Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness MethodologyAdam V Weizman, Geoffrey C Nguyen, Cynthia H Seow, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2022
Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN StudyOhad Atia, Eric I Benchimol, Natan Ledderman, et al.
World Journal of Gastroenterology|September 26, 2022
Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogueAlnoor Ramji, Karen Doucette, Curtis Cooper, et al.
Inflammatory Bowel Diseases|April 9, 2016
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness PanelShane M Devlin, Gil Y Melmed, Peter M Irving, et al.
Ebiomedicine|July 3, 2017
The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only StudyM Ellen Kuenzig, Jeff Yim, Stephanie Coward, et al.
Therapeutic Advances in Gastroenterology|June 20, 2022
The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018Yi-Ming He, Ren Mao, Gang Yuan, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBDCharles N Bernstein, Harminder Singh, Sanjay K Murthy, et al.
Pageof 90